Live Breaking News & Updates on Kate Beebe Devarney

Stay updated with breaking news from Kate beebe devarney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioCorRx Reports Business Update for the First Quarter of 2024

May 16, 2024 - BioCorRx Inc. , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the three months ended March. ....

United States , Lourdes Felix , Kate Beebe Devarney , National Institutes Of Health Under Award Number , Agreement Terms , End Addiction Initiative , Development Of Medications To , Exchange Commission , Biocorrx Pharmaceuticals Board Of Directors , National Institute On Drug Abuse , Biocorrx Inc , Biocorrx Pharmaceuticals , National Institutes Of Health , Trademark Office , National Survey On Drug , Biocorrx Pharmaceuticals Inc , Uncraverx Weight Loss Program , Corrx Inc , Corrx Pharmaceuticals , Drug Abuse , Beebe Devarney , Biocorrx Pharmaceuticals Board , United States Patent , Opioid Use Disorder , Corrx Pharmaceuticals Inc , End Addiction Long Term Initiative ,

BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors

ANAHEIM, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innov. ....

United States , Kate Beebe Devarney , Smithkline Beecham , Lourdes Felix , Weight Loss Program , American Psychiatric Association , National Institute Of Health , Titan Pharmaceuticals Inc , National Institute On Drug Abuse , Biocorrx Pharmaceuticals , American Society Of Addiction Medicine , Biocorrx Inc , Crescendo Communications , End Addiction Initiative , Agreement Terms , Journal Of The American Medical Association , National Advisory Committee On Drug Abuse , American College Of Neuropsychopharmacology , World Wide Human Health At Merck Co , Corcept Therapeutics Inc , Biocorrx Pharmaceuticals Inc , International Society Of Addiction Medicine , Development Of Medications To , Chief Operating Officer , Titan Pharmaceuticals , Chief Scientific Officer ,

BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors

BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Smithkline Beecham , Lourdes Felix , Kate Beebe Devarney , Crescendo Communications , National Advisory Committee On Drug Abuse , National Institute On Drug Abuse , Titan Pharmaceuticals Inc , National Institute Of Health , World Wide Human Health At Merck Co , American Society Of Addiction Medicine , American College Of Neuropsychopharmacology , American Psychiatric Association , Agreement Terms , International Society Of Addiction Medicine , Biocorrx Pharmaceuticals , Corcept Therapeutics Inc , Biocorrx Pharmaceuticals Inc , End Addiction Initiative , Development Of Medications To , Journal Of The American Medical Association , Weight Loss Program , Biocorrx Inc , Chief Operating Officer , Titan Pharmaceuticals , Chief Scientific Officer ,

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Kate Beebe Devarney , Titan Pharmaceuticals , Securities Exchange , Exchange Commission , Titan Pharmaceuticals Inc , Titan Pharmaceuticals Fully Compliant With , Nasdaq Stock Market , Nasdaq Capital , South San Francisco , Securities Act , Securities Exchange Act , Annual Report , Investor Contacts , Beebe Devarney , Chief Operating ,

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 Titan Pharmaceuticals, Inc. today announced that by letter dated January 24, 2024, the Company was notified by The Nasdaq Stock Market LLC that the. ....

Kate Beebe Devarney , Securities Exchange , Globenewswire Inc , Titan Pharmaceuticals Inc , Nasdaq Stock Market , Titan Pharmaceuticals , Exchange Commission , Nasdaq Capital , San Francisco , Securities Act , Securities Exchange Act , Annual Report , Investor Contacts , Beebe Devarney , Chief Operating ,